Medical technology player Trivitron Healthcare has acquired Finland-based Ani Labsystems, a player in invitro diagnostics, for €15.8 million. Ani Labsystems is a group of companies comprising Ani Biotech, Ani Labsystems, Biopoint and K3, specialising in manufacturing of neonatal screening, cardiac, gastro, respiratory diagnostics kits and infectious disease testing products.
Trivitron is acquiring all the group companies; the merged entity will be called Labsystems Diagnostics OY, a Trivitron group company. This 100 per cent acquisition gives Trivitron access to a global manufacturing facility. While neonatal screening, cardiac, gastro and respiratory diagnostics kits will continue to be manufactured at Helsinki Vantaa in Finland, the infectious diseases and women’s health kits will be manufactured at Trivitron’s medical technology park in Chennai, said a release.
The factory in Chennai will enable Trivitron to offer new product lines in South Asia, South-East Asia, West Asia and Africa, said G.S.K. Velu, Founder and Managing Director, Trivitron Healthcare.